![]() |
|
|
Vol. 298, Issue 3, 925-933, September 2001
University of Medicine and Dentistry of New Jersey, Robert Wood
Johnson Medical School, Department of Neurology, Piscataway, New
Jersey
Disturbance in phosphorylation/dephosphorylation can trigger apoptosis.
Little is known as to its effects on mesencephalic dopamine neurons,
the major neurons lost in Parkinson's disease. In this study, okadaic
acid (OKA), a phosphatase 1 and 2A inhibitor, with greater potency
toward 2A, was toxic to mesencephalic dopamine and
-aminobutyric
acid (GABA) neurons, however, dopamine neurons were 4-fold more
sensitive. The EC50 for dopamine versus GABA toxicity was
1.5 versus 6.5 nM, respectively, and was consistent with an inhibition
of phosphatase 2A. Dopamine neurons were also more sensitive to
calyculin-A, a phosphatase inhibitor equipotent toward 1 and 2A.
OKA-methyl-ester, which lacks phosphatase inhibitory activity, was
without effect. DNA laddering typical of apoptosis was observed in
cultures at a concentration that was specifically toxic to dopamine
neurons (5 nM). In contrast to the sensitivity of mesencephalic neurons
to phosphatase inhibition, inhibition of protein kinase activity with
staurosporine or K252a showed little toxicity and protected neurons
from OKA. Consistent with in vitro findings, infusion of 32 to 320 pmol
of OKA into the left striatum of rats caused a dose-dependent loss of
striatal dopamine without any loss of GABA 1 week following infusion.
Acutely, OKA increased tyrosine hydroxylase activity, a phosphatase 2A substrate, and increased dopamine turnover. The above-mentioned findings demonstrate that dysregulation of phosphatase activity is
detrimental to mesencephalic neurons, with dopamine neurons, in vitro
and in vivo, being relatively more sensitive to phosphatase 2A
inhibition. Disturbances in the phosphorylation control of proteins
unique to dopamine neurons may contribute to their enhanced vulnerability to OKA exposure.
This article has been cited by other articles:
![]() |
C. Y. Chung, J. B. Koprich, S. Endo, and O. Isacson An Endogenous Serine/Threonine Protein Phosphatase Inhibitor, G-Substrate, Reduces Vulnerability in Models of Parkinson's Disease J. Neurosci., August 1, 2007; 27(31): 8314 - 8323. [Abstract] [Full Text] [PDF] |
||||